HEADER PROTEIN FIBRIL 24-OCT-05 2BEG TITLE 3D STRUCTURE OF ALZHEIMER'S ABETA(1-42) FIBRILS COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID BETA A4 PROTEIN; COMPND 3 CHAIN: A, B, C, D, E; COMPND 4 FRAGMENT: BETA-AMYLOID PROTEIN 42; COMPND 5 SYNONYM: APP, ABPP, ALZHEIMER'S DISEASE AMYLOID PROTEIN, CEREBRAL COMPND 6 VASCULAR AMYLOID PEPTIDE, CVAP, PROTEASE NEXIN-II, PN-II, APPI; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: APP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSET KEYWDS ALZHEIMER'S, FIBRIL, PROTOFILAMENT, BETA-SANDWICH, QUENCHED KEYWDS 2 HYDROGEN/DEUTERIUM EXCHANGE, PAIRWISE MUTAGENESIS, PROTEIN FIBRIL EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR T.LUHRS,C.RITTER,M.ADRIAN,D.RIEK-LOHER,B.BOHRMANN,H.DOBELI, AUTHOR 2 D.SCHUBERT,R.RIEK REVDAT 4 09-MAR-22 2BEG 1 REMARK REVDAT 3 24-FEB-09 2BEG 1 VERSN REVDAT 2 20-DEC-05 2BEG 1 JRNL REVDAT 1 22-NOV-05 2BEG 0 JRNL AUTH T.LUHRS,C.RITTER,M.ADRIAN,D.RIEK-LOHER,B.BOHRMANN,H.DOBELI, JRNL AUTH 2 D.SCHUBERT,R.RIEK JRNL TITL 3D STRUCTURE OF ALZHEIMER'S AMYLOID-{BETA}(1-42) FIBRILS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 102 17342 2005 JRNL REFN ISSN 0027-8424 JRNL PMID 16293696 JRNL DOI 10.1073/PNAS.0506723102 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 1.0.6 REMARK 3 AUTHORS : GUNTERT, P., HERRMANN, T. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BEG COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000034997. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 1.0.6 REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: RESTRAINTS FOR THE CALCULATION OF THE STRUCTURE WERE REMARK 210 OBTAINED FORM QUENCHED HYDROGEN/DEUTERIUM EXCHANGE MEASUREMENTS, REMARK 210 CRYOGENIC ELECTRON MICROSCOPY, AND PAIRWISE MUTAGENESIS STUDIES REMARK 210 IN COMBINATION WITH THIOFLAVIN T FLUORESCENCE. FOR DETAILS ON REMARK 210 THE PROCESS, PLEASE REFER TO THE ORIGINAL PUBLICATION. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-10 REMARK 465 RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 PHE A 4 REMARK 465 ARG A 5 REMARK 465 HIS A 6 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 465 GLY A 9 REMARK 465 TYR A 10 REMARK 465 GLU A 11 REMARK 465 VAL A 12 REMARK 465 HIS A 13 REMARK 465 HIS A 14 REMARK 465 GLN A 15 REMARK 465 LYS A 16 REMARK 465 ASP B 1 REMARK 465 ALA B 2 REMARK 465 GLU B 3 REMARK 465 PHE B 4 REMARK 465 ARG B 5 REMARK 465 HIS B 6 REMARK 465 ASP B 7 REMARK 465 SER B 8 REMARK 465 GLY B 9 REMARK 465 TYR B 10 REMARK 465 GLU B 11 REMARK 465 VAL B 12 REMARK 465 HIS B 13 REMARK 465 HIS B 14 REMARK 465 GLN B 15 REMARK 465 LYS B 16 REMARK 465 ASP C 1 REMARK 465 ALA C 2 REMARK 465 GLU C 3 REMARK 465 PHE C 4 REMARK 465 ARG C 5 REMARK 465 HIS C 6 REMARK 465 ASP C 7 REMARK 465 SER C 8 REMARK 465 GLY C 9 REMARK 465 TYR C 10 REMARK 465 GLU C 11 REMARK 465 VAL C 12 REMARK 465 HIS C 13 REMARK 465 HIS C 14 REMARK 465 GLN C 15 REMARK 465 LYS C 16 REMARK 465 ASP D 1 REMARK 465 ALA D 2 REMARK 465 GLU D 3 REMARK 465 PHE D 4 REMARK 465 ARG D 5 REMARK 465 HIS D 6 REMARK 465 ASP D 7 REMARK 465 SER D 8 REMARK 465 GLY D 9 REMARK 465 TYR D 10 REMARK 465 GLU D 11 REMARK 465 VAL D 12 REMARK 465 HIS D 13 REMARK 465 HIS D 14 REMARK 465 GLN D 15 REMARK 465 LYS D 16 REMARK 465 ASP E 1 REMARK 465 ALA E 2 REMARK 465 GLU E 3 REMARK 465 PHE E 4 REMARK 465 ARG E 5 REMARK 465 HIS E 6 REMARK 465 ASP E 7 REMARK 465 SER E 8 REMARK 465 GLY E 9 REMARK 465 TYR E 10 REMARK 465 GLU E 11 REMARK 465 VAL E 12 REMARK 465 HIS E 13 REMARK 465 HIS E 14 REMARK 465 GLN E 15 REMARK 465 LYS E 16 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY A 37 H GLY B 38 1.55 REMARK 500 H PHE C 20 O PHE D 19 1.56 REMARK 500 O MET B 35 H VAL C 36 1.56 REMARK 500 H VAL B 39 O GLY C 38 1.56 REMARK 500 H VAL A 39 O GLY B 38 1.57 REMARK 500 O GLY C 33 H LEU D 34 1.58 REMARK 500 H PHE A 20 O PHE B 19 1.58 REMARK 500 H GLY B 37 O VAL C 36 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 20 77.20 -108.45 REMARK 500 1 ASN A 27 163.87 63.24 REMARK 500 1 LYS A 28 113.36 60.35 REMARK 500 1 ALA A 30 -146.79 42.61 REMARK 500 1 ASN B 27 69.32 62.91 REMARK 500 1 LYS B 28 -95.92 -73.15 REMARK 500 1 ALA B 30 -144.14 64.86 REMARK 500 1 ASN C 27 67.98 80.03 REMARK 500 1 LYS C 28 -101.00 -64.81 REMARK 500 1 ALA C 30 -142.63 58.05 REMARK 500 1 ASN D 27 76.62 78.39 REMARK 500 1 LYS D 28 -92.64 -67.25 REMARK 500 1 ALA D 30 -144.64 44.62 REMARK 500 1 ASN E 27 78.08 72.23 REMARK 500 1 LYS E 28 -81.19 -72.19 REMARK 500 1 ALA E 30 -148.87 47.17 REMARK 500 2 ASN A 27 102.79 81.13 REMARK 500 2 ASN B 27 51.92 82.28 REMARK 500 2 LYS B 28 171.76 -50.34 REMARK 500 2 ASN C 27 90.54 84.20 REMARK 500 2 ALA C 30 -109.30 165.22 REMARK 500 2 ASN D 27 43.33 76.64 REMARK 500 2 ALA D 30 -157.82 -158.49 REMARK 500 2 ASN E 27 -52.95 80.80 REMARK 500 2 LYS E 28 88.29 39.81 REMARK 500 2 ALA E 30 -138.47 -130.87 REMARK 500 3 ASN A 27 76.95 71.32 REMARK 500 3 ALA A 30 -152.38 71.04 REMARK 500 3 ASN B 27 92.63 80.20 REMARK 500 3 ALA B 30 -122.01 63.11 REMARK 500 3 ASN C 27 70.44 82.83 REMARK 500 3 ALA C 30 -94.29 67.82 REMARK 500 3 ASN D 27 63.35 82.68 REMARK 500 3 ALA D 30 -158.58 171.25 REMARK 500 3 ASN E 27 53.27 81.64 REMARK 500 3 ALA E 30 -95.81 59.50 REMARK 500 4 ASN A 27 -171.31 72.11 REMARK 500 4 LYS A 28 165.64 58.38 REMARK 500 4 ASN B 27 94.86 66.93 REMARK 500 4 LYS B 28 -178.19 -50.23 REMARK 500 4 ALA B 30 -84.89 -62.51 REMARK 500 4 ASN C 27 89.49 53.59 REMARK 500 4 LYS C 28 167.63 -43.69 REMARK 500 4 ALA C 30 -75.24 -48.18 REMARK 500 4 ASN D 27 84.77 77.78 REMARK 500 4 ALA D 30 -143.07 36.44 REMARK 500 4 ASN E 27 86.00 70.46 REMARK 500 4 ALA E 30 -155.84 51.06 REMARK 500 5 ASN A 27 45.96 78.82 REMARK 500 5 ALA A 30 -158.42 83.54 REMARK 500 REMARK 500 THIS ENTRY HAS 112 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2BEG A 1 42 UNP P05067 A4_HUMAN 672 713 DBREF 2BEG B 1 42 UNP P05067 A4_HUMAN 672 713 DBREF 2BEG C 1 42 UNP P05067 A4_HUMAN 672 713 DBREF 2BEG D 1 42 UNP P05067 A4_HUMAN 672 713 DBREF 2BEG E 1 42 UNP P05067 A4_HUMAN 672 713 SEQRES 1 A 42 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 A 42 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 A 42 ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY GLY VAL SEQRES 4 A 42 VAL ILE ALA SEQRES 1 B 42 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 B 42 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 B 42 ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY GLY VAL SEQRES 4 B 42 VAL ILE ALA SEQRES 1 C 42 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 C 42 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 C 42 ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY GLY VAL SEQRES 4 C 42 VAL ILE ALA SEQRES 1 D 42 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 D 42 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 D 42 ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY GLY VAL SEQRES 4 D 42 VAL ILE ALA SEQRES 1 E 42 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 E 42 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 E 42 ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY GLY VAL SEQRES 4 E 42 VAL ILE ALA SHEET 1 A 5 VAL A 18 SER A 26 0 SHEET 2 A 5 VAL B 18 SER B 26 1 O PHE B 19 N PHE A 20 SHEET 3 A 5 VAL C 18 SER C 26 1 O GLY C 25 N SER B 26 SHEET 4 A 5 VAL D 18 SER D 26 1 O PHE D 19 N PHE C 20 SHEET 5 A 5 VAL E 18 SER E 26 1 O ASP E 23 N VAL D 24 SHEET 1 B 5 ILE A 31 ILE A 41 0 SHEET 2 B 5 ILE B 31 ILE B 41 1 O GLY B 38 N VAL A 39 SHEET 3 B 5 ILE C 31 ILE C 41 1 O GLY C 38 N VAL B 39 SHEET 4 B 5 ILE D 31 ILE D 41 1 O VAL D 36 N MET C 35 SHEET 5 B 5 ILE E 31 ILE E 41 1 O LEU E 34 N GLY D 33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1